ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

New Publications

March 16, 1990

In Congress: DOD Cancer Research Programs Increased; Senate Passes NIH Funding Bill; Porter Won’t Seek Re-election

October 22, 1999

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011

In Brief: Brandt Names To Health Position; Everett Koop Would Be Surgeon General In HHS Reorganization

February 20, 1981

ACCC Annual Meeting To Study Organizing Community Care

January 26, 1979

DCE Board Approves Concepts For Three New RFA Programs

July 6, 1984